For profitable contract research organizations, timing is everything. CROs that facilitate rapid and efficient release of new drugs and medical technology for sponsor businesses can claim a greater portion of the $76.6 billion global market. Yet as of this writing, there are 463,610 global clinical trials—whether interventional, observational, or expanded access— meaning there’ll be fierce rivalries in the race to reach major breakthroughs first.